| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
IDA[11994271]
|
| ADRBK2 |
adrenergic, beta, receptor kinase 2 |
22q11 |
3(2/1/0)
|
IEA
|
| PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
7q35-q36 |
1(1/0/0)
|
IEA
|
| NEK4 |
NIMA-related kinase 4 |
3p21.1 |
1(1/0/0)
|
ISS
|
| PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
ISS
|
| STK24 |
serine/threonine kinase 24 |
13q31.2-q32.3 |
2(1/1/0)
|
IDA[19604147]
|
| FYN |
FYN proto-oncogene, Src family tyrosine kinase |
6q21 |
1(1/0/0)
|
NAS[7822789]
|
| EIF2AK4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
15q13.3 |
1(0/1/0)
|
ISS
|
| CSNK1E |
casein kinase 1, epsilon |
22q13.1 |
5(1/3/1)
|
IDA[15917222]; ISS
|
| PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
1(1/0/0)
|
IEA
|
| NEK7 |
NIMA-related kinase 7 |
1q31.3 |
2(0/1/1)
|
IDA[12840024]
|
| TRIB1 |
tribbles pseudokinase 1 |
8q24.13 |
1(0/0/1)
|
TAS[20410507]
|
| TAOK2 |
TAO kinase 2 |
16p11.2 |
1(0/1/0)
|
IEA
|
| PRKCZ |
protein kinase C, zeta |
1p36.33-p36.2 |
1(1/0/0)
|
IDA[10770950]
|
| PRKCE |
protein kinase C, epsilon |
2p21 |
1(0/1/0)
|
IDA[18556656]
|
| PSKH1 |
protein serine kinase H1 |
16q22.1 |
1(1/0/0)
|
IEA
|
| MAPK10 |
mitogen-activated protein kinase 10 |
4q22-q23 |
1(0/1/0)
|
IMP[22441692]; ISS
|
| CCL2 |
chemokine (C-C motif) ligand 2 |
17q11.2-q21.1 |
3(1/2/0)
|
TAS[9670957]
|
| P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
IEA
|
| PICK1 |
protein interacting with PRKCA 1 |
22q13.1 |
1(0/1/0)
|
ISS
|
| CAMKK2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
12q24.2 |
2(1/1/0)
|
IDA[11395482]
|
| CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
20p13 |
2(0/2/0)
|
IDA[20625391]
|
| VRK2 |
vaccinia related kinase 2 |
2p16.1 |
1(0/1/0)
|
TAS[9344656]
|
| JAK1 |
Janus kinase 1 |
1p32.3-p31.3 |
1(0/1/0)
|
TAS[1848670]
|
| PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
7q22 |
1(0/0/1)
|
IEA
|
| CDC25B |
cell division cycle 25B |
20p13 |
1(0/1/0)
|
IDA[17332740]
|
| CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
5q32 |
2(1/1/0)
|
IDA[17052756]
|
| CIT |
citron rho-interacting serine/threonine kinase |
12q24.23 |
2(1/1/0)
|
IEA
|
| ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
8q24.22 |
4(3/0/1)
|
IEA
|
| RIOK1 |
RIO kinase 1 |
6p24.3 |
2(1/0/1)
|
IEA
|
| STK39 |
serine threonine kinase 39 |
2q24.3 |
2(0/2/0)
|
NAS[10980603]
|
| PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
IDA[12420224]
|
| AURKB |
aurora kinase B |
17p13.1 |
1(1/0/0)
|
IDA[21820309]
|
| CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
14q32.32 |
1(0/1/0)
|
IDA[21949762]; ISS
|
| CREB1 |
cAMP responsive element binding protein 1 |
2q34 |
2(1/1/0)
|
IDA[8798441]
|
| BCR |
breakpoint cluster region |
22q11 |
2(1/1/0)
|
TAS[1657398]
|
| PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
18q12.3 |
1(1/0/0)
|
IEA
|
| TRIO |
trio Rho guanine nucleotide exchange factor |
5p14-p15.1 |
1(0/1/0)
|
IEA
|
| GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
IDA[11035810]
|
| MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
1p36 |
1(0/0/1)
|
IDA[15467718]; IMP[17028174]
|
| NEK5 |
NIMA-related kinase 5 |
13q14.2 |
1(0/1/0)
|
IBA
|
| CSNK1D |
casein kinase 1, delta |
17q25 |
4(2/2/0)
|
IDA[16618118]
|
Basic Info
